Clinical Trial Update: Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating emergent revascularization of occluded coronaries in cardiogenic shock. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock
• Cardiovascular Diseases
• Coronary Artery Disease
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: Carelon Research | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED